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ABSTRACT 
 
Background: Zinc acts as growth protector for neoplastic cells and its deficiency 
was contributed to carcinogenesis.  However, the determinations of serum zinc 
in acute lymphocytic leukemia (ALL) prediction and prognosis requires more 
investigations. Objective: To evaluate and compare serum zinc in ALL patients 
and healthy controls and to correlate the serum zinc levels with hematological 
prognostic markers.  Materials and methods: the study was conducted in 
Khartoum state-Sudan during the period from December 2013 to September  
2014, it involved a case group of ALL patients (N=100) matched for age and 
gender with a control group (N=100). Serum copper and zinc levels and full  blood 
count were investigated.  Results: The ALL patients showed lower levels of Zn 
0.73 ± 0.18 mg/dl compared to controls 1.01 ± 0.25 mg/dl [P = 0.003]. The serum 
Zn levels were inversely correlated with total white cell  (-0.804, P < 0.0001) and 
blast counts (-0.935, P < 0.0001) Conclusion: These findings ALL associated with 
lower serum zinc levels and higher serum copper levels. The determination of 
serum zinc and copper could be used as ALL prognostic markers.  
 
INTRODUCTION 
Acute lymphoblastic leukemia (ALL) is a malignancy  of the 
lymphocyte progenitor cells or the lymphoblasts which 
accounts about 75% of childhood leukemias and 20% of 
leukemias in adults  [1]. Til l now, the exact cause of ALL remains 
unknown, but it is l ikely to involve a complex interaction 
between genetic susceptibility and environmental exposure[2]. 
The pivotal role of trace elements in the process of normal 
proliferation and differentiation of various tissues in animals 
and humans has been reported[3]. As they may affect tumor  
cell  proliferation, their levels are considered to be of 
significant importance in carcinogenesis [4]. Some of these 
elements exert their preventive role against malignant 
proliferation by participating protection against oxidative 
stress exerted by free radicals in the cells that contribute to 
cancer development[9]. 
Zinc (Zn), an essential trace element, a component of more 
than 200 enzymes, plays an important role in the maintenance 
of several tissue functions [6]. Zn is an essential mineral that is 
integral to many transcription factors that regulate key cellular  
 
functions such as the response to oxidative stress, DNA 
replication, DNA damage repair, cell  cycle progression, and 
apoptosis. In particular, several proteins involved in DNA 
damage signaling and repair, replicative enzymes such as DNA 
and RNA polymerases and transcription factors such as 
tumour protein p5317[7]. Trace amount of Zn is required in the 
diet, which is around 15 mg Zn/day[8], with a total amount in 
the adult body being in average of 1.4-2.3 g [9]. The estimation 
of circulating levels of Zn either in plasma or serum has been 
the most widely used approach for the assessment of zinc 
nutrition[10]. It has been reported that changes in zinc serum 
levels may play an important biologic in the initiation and  
development of tumor mass [11]. 
MATERIAL & METHOD  
Study design: The study was analytical observation study  
Ethics approval: A written consent was obtained from the 
parents/ caregivers of the subjects and controls after  
explaining to them, in detail, the objectives of the study as well 
as the method of specimen collection. 
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Sample size: One hundred patients with ALL as case group and 
100 apparently healthy individuals as control group were 
included in this study. The controls were age- and gender - 
matched for cases.   The patients were attendants of clinics 
and hospital  in Khartoum state, Sudan from December 2013 
to September 2014.  
Case group: The diagnosis was confirmed by examination of 
both peripheral blood and bone marrow examination. All  the 
patients were enrolled in the study before receiving the first 
course of chemotherapy. The control group was used only for 
comparing serum zinc. 
Inclusion criteria: Both male and female Sudanese patients 
confirmed with ALL in Khartoum state at presentation at any 
age and before starting chemotherapy. 
Exclusion criteria: Recent blood transfusion history, taking any 
medication with mineral supplement or drugs that affect iron 
metabolism or starting chemotherapy.   
Blood sample collection: Five ml of fasting blood sample was 
collected from the antecubital vein of each of the case and 
control group.  Three ml were poured into EDTA 
anticoagulated tube the rest of the sample was poured into 
plain tube.  Samples with signs of hemolysis were discarded. 
The blood was then centrifuged for 15 minutes at 3000 rpm to 
extract the serum. The serum was aliquoted into deionised 
polyethylenetubes and stored at -80°C.  
Full blood count (CBC): Full blood count was performed from 
EDTA samples within half hour after collection using 
automated blood cell  counter to obtain total white cell  count. 
A microscopic examination of peripheral blood fi lm was done 
to get the blast count.  
Biochemical Analysis: Serum concentrations of Zn in both 
patients and controls were determined by using atomic 
absorption spectrophotometry. 
Statistical Analysis: One-way ANOVA was used for the 
comparison of mean values of the groups. Then, Student-t test 
was used to determine the difference between groups. 
Pearson correlation analysis was used to study the 
relationship between serum Zn with total white cell  count and 
blast count.  A “p” value <0.05 was considered statistically 
significant. Statistical analyses were carried out using the 
SPSS® statistical software package (SPSS for Windows version 
21.0 SPSS Inc., Chicago, Il l inois, USA). All  results are expressed 
as mean and standard deviation (mean ± SD). 
RESULTS 
One hundred patients with ALL (54 male, 46 females; mean 
age 22.6 ± 18.8 years) and 100 healthy subjects (55 male, 45 
female; mean age 19.9 ± 19.7 years) comprised the study 
group, table 1.  
 
 
 
 
Table 1. The distribution of gender age of participants 
Parameters Cases (n=100) Controls 
(n=100) 
P 
value 
 Males Females Males Females - 
Frequency 54 46 55 45(45%) 
Age (years) 22.6 ± 18.8 19.9 ± 19.7   
LDH 0.73 ± 0.18 1.01 ± 0.25 0.003 
 
 
Figure 1. levels of serum Zn in ALL patients and controls  
Pearson correlation analysis among ALL, showed a highly 
significant an inverse correlation between serum Zn levels and 
white blood cell  counts (r = 0.46, p < 0.04) as well as with the 
number of blast cells (r = 0.8, p< 0.001), Table 2. 
Table 2. Correlation of serum Zn with WBC and blast cell in 
ALL patients 
 White cell  
count/ µl  
Blast cell   
count/ µl  
Mean ± SD  176.3± 45.8 122± 39.9    
Pearson correlation (r) -0.804 -0.935 
P-value < 0.0001 < 0.0001 
DISCUSSION  
The present study was designed to evaluate serum Zn in ALL 
patients. Also correlations have been made between the 
serum levels of Zn and total white cell  count and blast count 
within the case group.  
In addition to its major function and metabolic effect 
described above, the accumulation of high zinc levels can have 
other consequences. One such effect is the inhibition of cell  
growth, which results from its induction of mitochondrial 
apoptogenesis [12,13]. 
The maintenance of discrete subcellular pools of zinc is critical 
for the functional and structural integrity of cells. Among the 
important biological processes influenced by Zn is 
apoptosis [14]. 
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It has also been identified as a major mechanism contributing 
to cell  death in response to toxins and in disease, offering hope 
that novel therapies that target apoptotic pathways may be 
developed. Zinc becomes cytotoxic if its extracellular 
concentration exceeds the capacity of the Zn homeostatic 
system. Elevated extracellular Zn concentrations  lead to the 
breakdown of the Zn transporting system of the plasma 
membrane. The resulting enhanced intracellular Zn 
concentration activates the apoptosis [15]. Zn releases 
cytochrome C from mitochondria so that some enzymes  
named caspases will  be activated which finally result in 
apoptosis [16]. Zn also causes reduction of tumor cells and 
tumor size[17]. Esophageal Squamous Cell Carcinoma with TP53 
mutant tumor had lower zinc levels than those with no 
mutation[18]. 
Our results indicate that the serum Zn in ALL patients is lower 
than in control subjects. This is in agreement with previous 
data [19,20]. Our results indicating that serum Zn showed an 
inverse association with some hematological markers of ALL; 
total white cell  count and blast count, which are used in index 
to predict the response to chemotherapy.  The accumulation 
of high intracellular levels of zinc by tumor cells induces 
mitochondrial apoptogenesis [12]. Consequently the availability 
of Zn in blast cells could induce its apoptosis and thus 
decreasing its count which is parallel to mass in solid tumor.  
CONCLUSION  
Zinc deficiency contributes to carcinogenic factors in ALL, thus 
the correction of reduced Zn could prevent or at least 
decrease the severity onset of the disease. The inverse 
association between Zn and total white cell  and blast count 
could emphasize the role of incorporation Zn in treatment 
protocol. 
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